This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / VVT Med Inc. Regulatory Filing Delay
Regulatory regulatory non-compliance

VVT Med Inc. Regulatory Filing Delay

Analysis based on 6 articles · First reported May 29, 2026 · Last updated Jun 12, 2026

Sentiment
-40
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The delay in filing financial statements and the subsequent management cease trade order by the Canada — British Columbia Securities Commission negatively impact investor confidence in VVT Medical, potentially leading to a decrease in its stock price. The restrictions on trading for the CEO and CFO also signal a lack of transparency and operational issues, which could deter new investments.

Medical Devices Healthcare
Event Summary

VVT Medical has been under a management cease trade order (MCTO) issued by the Canada — British Columbia Securities Commission since April 17, 2026, due to its failure to file audited financial statements for the year ended December 31, 2025, and related management's discussion and analysis. This delay also caused the company to miss the deadline for its interim financial statements for the three months ended March 31, 2026. The company, including its CEO Erez Tetro, and its auditors are working to complete these 'Required Filings' and 'Interim Filings' by June 29, 2026. The MCTO prohibits the chief executive officer and chief financial officer from trading in VVT Medical securities and restricts the company from issuing or acquiring securities from insiders or employees, except for pre-existing obligations.

Entities Involved
priv
VVT Medical
VVT Medical is facing a management cease trade order due to delays in filing its annual and interim financial statements, which restricts trading for its CEO and CFO and impacts its stock price.
Importance 100.0 Sentiment -50.0
per
Erez Tetro
Erez Tetro, as the Chief Executive Officer of VVT Medical, is prohibited from trading in the company's securities due to the management cease trade order.
Importance 60.0 Sentiment -30.0
exch
TSX Venture Exchange
Importance 0 Sentiment 0
govactor
Canada — British Columbia Securities Commission
Importance 0 Sentiment 0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.